Inactive Instrument

Exceed World, Inc. Stock Other OTC

Equities

EXDW

US30067B1026

Drug Retailers

Sales 2022 34.69M Sales 2023 25.92M Capitalization 22.89M
Net income 2022 4M Net income 2023 - EV / Sales 2022 0.1 x
Net cash position 2022 23.36M Net cash position 2023 17.53M EV / Sales 2023 0.21 x
P/E ratio 2022
6.48 x
P/E ratio 2023
-35 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 7.05%
More Fundamentals * Assessed data
Dynamic Chart
Exceed World, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Exceed World, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Exceed World, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Exceed World, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Exceed World, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
Exceed World, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Exceed World, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022 CI
Exceed World, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021 CI
Exceed World, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021 CI
Exceed World, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021 CI
Exceed World, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021 CI
Exceed World, Inc. Reports Earnings Results for the Full Year Ended September 30, 2020 CI
Exceed World, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2020 CI
Exceed World, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2020 CI
Exceed World, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2019 CI
More news
Managers TitleAgeSince
Chief Executive Officer 61 16-01-11
Members of the board TitleAgeSince
Chief Executive Officer 61 16-01-11
More insiders